Sweetgreen is trading at $5.83, down 7.09%, after August 6 second-quarter results missed estimates and management sharply reduced 2026 guidance.
- Same-store sales are projected to decline 7%-8%, versus the previous 2%-4% outlook, as cyclospora fears reduced demand for fresh produce.
- Sweetgreen has not been linked to the outbreak, but concerns continue weighing on customer traffic and recovery expectations.
- Broader markets are only modestly lower, making the company-specific guidance reaction the primary explanation.